Jing-Jing Li

11PUBLICATIONS
42CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 17, 2026
ARID1A Stimulates Notch-TLL1 Signaling to Induce Cancer-Associated Fibroblast Activation and Intrahepatic Cholangiocarcinoma Development.

|Jul 03, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

|Aug 07, 2025
PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

Bing Zhu, Ning Ma, Zhi-Chao Liu

|Jan 19, 2024
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Kang Wang, Yan-Jun Xiang, Hong-Ming Yu

|Dec 14, 2023
XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis.

Ji Xia, Ning Ma, Qian Shi

|Jul 26, 2023
Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.

Qian-Wen Zheng, Qian-Zhi Ni, Bing Zhu

Pageof 2

Frequent Collaborators

9 joint publications

Ning Ma

6 joint publications

Dong Xie

4 joint publications

Shuqun Cheng

4 joint publications

Yan-Jun Xiang